CSF3, also known as Granulocyte colony-stimulating factor, increases with age in the ME/CFS cohort but is lower with age in the total cohort, perhaps indicating an inflammatory state in the patient cohort. The gene discussed is CSF3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.